With the majority of the European Union countries opening their borders for non-essential travel, most of them decided to keep in place vaccination requirements in order to protect public health and avoid any possible resurgence of new COVID-19 infections.
Nonetheless, since each EU Member State has the right to decide on its entry requirements, the travel process has been confusing for travellers for quite some time now as a large share of EU countries recognise for travel only vaccines that have been approved for use by the European Medicines Agency (EMA).
Still, soon after the World Health Organization (WHO) disclosed that Covaxin had been officially approved for use, 12 EU countries automatically accepted the vaccine as valid proof of immunity for travel, SchengenVisaInfo.com reports.
Based on the data provided by VisaGuide.World’s vaccine-checker tool, which enables travellers to verify the validity of their vaccine, all of the EU/Schengen Area countries listed below now recognise Covaxin as valid proof of immunity against the COVID-19:
Switzerland was one of the first countries to recognise the Covaxin vaccine.
All of the authorities of the countries mentioned above have announced that they accept all vaccination certificates that indicate that the holder has been immunised with one of the vaccines approved by WHO.
This means that as soon as Covaxin got the green light from WHO, the vaccine was automatically accepted in these countries.
“A person who has received a full vaccination course with any vaccine registered by the European Medicines Agency or an equivalent vaccine registered by a regulator or recognised by the World Health Organisation and 14 days have passed since the completion of the vaccination course,” the statement of the Latvian authorities reads.
In line with the majority of EU countries’ requirements, the vaccination document that indicates that the holder has been immunised with Covaxin must include essential information on the holder, including name and last name, birthdate, and dates when the doses were administered, as well as the issuing body.
According to a press release issued by WHO, the assessment of Covaxin was based on the review of data on safety, quality, efficacy, risk management, and programmatic suitability.
The vaccine is exceptionally suitable to countries with low and middle incomes due to its simple storage requirements and is recommended in two doses for all persons over the age of 18.
Apart from the countries mentioned above that now allow entry to all those vaccinated with Covaxin, the Maltese authorities just recently announced that travellers jabbed with WHO-approved vaccines followed by an EMA-accepted booster shot will be permitted entry to the country.
This means that all travellers vaccinated with Covaxin can now travel to Malta without being subject to additional entry rules provided that they have taken a booster shot of one of the vaccines approved by EMA.